Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vidal Essebag

Showing results (141-150 of 185) with videos related to

Pageof 19
Sort By:
The Canadian Journal of Cardiology|December 31, 2016
Canadian Cardiovascular Society/Canadian Heart Rhythm Society 2016 Implantable Cardioverter-Defibrillator GuidelinesMatthew Bennett, Ratika Parkash, Pablo Nery, et al.
JACC. Clinical Electrophysiology|May 26, 2018
Cost Effectiveness of Ventricular Tachycardia Ablation Versus Escalation of Antiarrhythmic Drug Therapy: The VANISH TrialKathryn Coyle, Doug Coyle, Isabelle Nault, et al.
European Heart Journal|November 22, 2018
Continued vs. interrupted direct oral anticoagulants at the time of device surgery, in patients with moderate to high risk of arterial thrombo-embolic events (BRUISE CONTROL-2)David H Birnie, Jeff S Healey, George A Wells, et al.
Heart Rhythm|July 11, 2025
Atrial fibrillation progression in patients with device-detected subclinical atrial fibrillation: Insights from the ARTESiA trialGiuseppe Boriani, William F McIntyre, Chinthanie Ramasundarahettige, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|April 23, 2014
Snapshot of adult invasive cardiac electrophysiology in Canada: results of the web-based registryMohammed Shurrab, Evgeny Fishman, Anna Kaoutskaia, et al.
Circulation. Arrhythmia and Electrophysiology|October 14, 2016
Canadian Registry of Implantable Electronic Device Outcomes: Surveillance of the Riata Lead Under AdvisoryRatika Parkash, Bernard Thibault, Iqwal Mangat, et al.
Heart Rhythm|October 26, 2011
Nonphysiologic noise early after defibrillator implantation in Canada: incidence and implications: a report from the Canadian Heart Rhythm Society Device CommitteeVidal Essebag, Jean Champagne, David H Birnie, et al.
The New England Journal of Medicine|November 16, 2020
Cryoablation or Drug Therapy for Initial Treatment of Atrial FibrillationJason G Andrade, George A Wells, Marc W Deyell, et al.
Heart Rhythm|August 27, 2013
The Canadian experience with Durata and Riata ST Optim defibrillator leads: a report from the Canadian Heart Rhythm Society Device CommitteeMatthew T Bennett, Andrew C T Ha, Derek V Exner, et al.
The American Journal of Cardiology|March 3, 2015
Risk stratification and stroke prevention therapy care gaps in Canadian atrial fibrillation patients (from the Co-ordinated National Network to Engage Physicians in the Care and Treatment of Patients With Atrial Fibrillation chart audit)Ashish D Patel, Mary K Tan, Paul Angaran, et al.
Pageof 19

Showing results (141-150 of 185) with videos related to

Sort By:
Pageof 19
The Canadian Journal of Cardiology|December 31, 2016
Canadian Cardiovascular Society/Canadian Heart Rhythm Society 2016 Implantable Cardioverter-Defibrillator GuidelinesMatthew Bennett, Ratika Parkash, Pablo Nery, et al.
JACC. Clinical Electrophysiology|May 26, 2018
Cost Effectiveness of Ventricular Tachycardia Ablation Versus Escalation of Antiarrhythmic Drug Therapy: The VANISH TrialKathryn Coyle, Doug Coyle, Isabelle Nault, et al.
European Heart Journal|November 22, 2018
Continued vs. interrupted direct oral anticoagulants at the time of device surgery, in patients with moderate to high risk of arterial thrombo-embolic events (BRUISE CONTROL-2)David H Birnie, Jeff S Healey, George A Wells, et al.
Heart Rhythm|July 11, 2025
Atrial fibrillation progression in patients with device-detected subclinical atrial fibrillation: Insights from the ARTESiA trialGiuseppe Boriani, William F McIntyre, Chinthanie Ramasundarahettige, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|April 23, 2014
Snapshot of adult invasive cardiac electrophysiology in Canada: results of the web-based registryMohammed Shurrab, Evgeny Fishman, Anna Kaoutskaia, et al.
Circulation. Arrhythmia and Electrophysiology|October 14, 2016
Canadian Registry of Implantable Electronic Device Outcomes: Surveillance of the Riata Lead Under AdvisoryRatika Parkash, Bernard Thibault, Iqwal Mangat, et al.
Heart Rhythm|October 26, 2011
Nonphysiologic noise early after defibrillator implantation in Canada: incidence and implications: a report from the Canadian Heart Rhythm Society Device CommitteeVidal Essebag, Jean Champagne, David H Birnie, et al.
The New England Journal of Medicine|November 16, 2020
Cryoablation or Drug Therapy for Initial Treatment of Atrial FibrillationJason G Andrade, George A Wells, Marc W Deyell, et al.
Heart Rhythm|August 27, 2013
The Canadian experience with Durata and Riata ST Optim defibrillator leads: a report from the Canadian Heart Rhythm Society Device CommitteeMatthew T Bennett, Andrew C T Ha, Derek V Exner, et al.
The American Journal of Cardiology|March 3, 2015
Risk stratification and stroke prevention therapy care gaps in Canadian atrial fibrillation patients (from the Co-ordinated National Network to Engage Physicians in the Care and Treatment of Patients With Atrial Fibrillation chart audit)Ashish D Patel, Mary K Tan, Paul Angaran, et al.
Pageof 19